Results 11 to 20 of about 1,669,669 (220)

Anticardiolipin antibodies in pathogenesis of infertility [PDF]

open access: yesVojnosanitetski Pregled, 2010
Background/Aim. Antiphospholipid syndrome (APS) is an autoimmune disorder clinically characterized by arterial or venous thrombosis and/or specific obstetric complications and presence of antiphospholipid antibodies (aPL) in the serum.
Lončar Dragan
doaj   +3 more sources

Anticardiolipin antibodies and severe leptospirosis [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2003
Laurent RODA
doaj   +5 more sources

Study on Anticardiolipin Antibodies in Women With Recurrent Abortion in Duhok Province, Kurdistan Region, Iraq

open access: yesActa Medica Iranica, 2020
Recurrent abortion is a worldwide issue. Anticardiolipin antibodies (ACA) are found to be among the most important factors related to recurrent spontaneous early pregnancy loss.
Ibrahim A Naqid   +4 more
doaj   +1 more source

Changes in the Level of Antiphospholipid Antibodies (Anticardiolipin and Anti-β2-Glycoprotein-I) and Thromboembolic Indices in COVID-19 Patients during 3 Weeks

open access: yesInternational Journal of Preventive Medicine, 2023
Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19.
Somayeh Haghighipour   +5 more
doaj   +1 more source

Prevalence of anticardiolipin antibody IgM and IgG in women with recurrent abortions in Kirkuk city

open access: yesNTU Journal of Pure Sciences, 2023
Toxoplasma gondii, a parasite that can produce a wide range of clinical symptoms in humans, is the source of the zoonotic infection known as Toxoplasmosis.
Muna Aziz, Abeer Ali, Mohammed Hameed
doaj   +1 more source

Antiphospholipid Antibodies in Patients with Type 2 Diabetes Mellitus [PDF]

open access: yesAnnals of the College of Medicine Mosul, 2020
Patients with diabetes mellitus type 2 have a greater risk of accelerated atherosclerosis. Antiphospholipid antibodies(aPL)are associated with greater risk for thrombosis.
Nada Hasso, Ahmed Hussain, Ali Fatheel
doaj   +1 more source

SARS-CoV-2 and Anti-Cardiolipin Antibodies

open access: yesClinical Medicine Insights: Case Reports, 2020
The current COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to distinct diagnostic and management challenges for front-line healthcare workers. The risk of excessive coagulation activation leading to a
Mazen Jizzini, Mohsin Shah, Kehua Zhou
doaj   +1 more source

Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

open access: yesJournal of Thrombosis and Haemostasis, 2022
Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti‐β2 glycoprotein I (aβ2GPI) IgG/IgM antibodies.
A. Vandevelde   +7 more
semanticscholar   +1 more source

METABOLIC AND AUTOIMMUNE RISK FACTORS FOR CORONARY ARTERY DISEASE (CAD) IN HEART TRANSPLANT RECIPIENTS

open access: yesВестник трансплантологии и искусственных органов, 2010
One of the most essential autoimmunity risk factors for development of CAD are increasing level of anticardiolipin antibodies and homocystein. This report presents retrospective analyses of 39 heart transplant recipients with maximal follow up over 16 ...
T. A. Khalilulin   +6 more
doaj   +1 more source

Hepatic venous outflow block in a young patient with Systemic Lupus Erythematosus [PDF]

open access: yesJournal of Analytical Research in Clinical Medicine, 2015
Introduction: Hepatic venous outflow block or Budd-Chiari syndrome is a severe liver disease with a 3 years survival rate of 50%. Several conditions have been implicated as a cause of Budd-Chiari syndrome, including myeloproliferative disorders ...
Ali Ghavidel
doaj   +1 more source

Home - About - Disclaimer - Privacy